Dishman Pharmaceuticals and Chemicals shares gained as much as 9 per cent to touch a day's high of Rs 149 after the company announced that the inspection at its Bavla facility in Gujarat has been successfully completed by US Food and Drug Regulator.
In a filing to BSE, Dishman Pharmaceuticals and Chemicals said that renewal of US FDA inspection of Company's Bavla facility has been successfully completed on July 08, 2016.
Shares of Dishman Pharmaceuticals and Chemicals ended at Rs 140, up 3 per cent outperforming the broad market indicator Sensex which closed 1.84 per cent higher.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
